Publications by authors named "Edwin van de Ketterij"
Criteria for treatment-resistant depression (TRD) and partially responsive depression (PRD) as subtypes of major depressive disorder (MDD) are not unequivocally defined. In the present document we used a Delphi-method-based consensus approach to define TRD and PRD and to serve as operational criteria for future clinical studies, especially if conducted for regulatory purposes. We reviewed the literature and brought together a group of international experts (including clinicians, academics, researchers, employees of pharmaceutical companies, regulatory bodies representatives, and one person with lived experience) to evaluate the state-of-the-art and main controversies regarding the current classification.
View Article and Find Full Text PDFArticle Synopsis
- Neurofibromatosis (NF) includes three types: NF1, NF2, and schwannomatosis (SWN), and researchers want to improve drug testing for these conditions.
- A study looked at recent drug trials for NF, finding that most focused on NF1 and NF2, and many trials had very few patients involved.
- The research highlighted the need for more trials on different types of NF symptoms and suggested that working together internationally could help develop better treatments.